Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Serotonin (5-HT) and dopamine (DA) systems in the prefrontal cortex (PFC) are implicated in cognitive disorders like schizophrenia.
• Understanding the interaction between these neurotransmitter systems is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the effect of local 5-HT application on extracellular DA levels in the PFC.
• To compare this effect with that observed in the striatum.
• To identify the specific 5-HT receptor subtype involved in modulating DA release in the PFC.

Main Methods:

• Microdialysis was used to measure extracellular DA levels in the PFC and striatum.
• 5-HT was applied locally to the PFC.
• Pharmacological agents, including selective 5-HT receptor antagonists and agonists, were used to characterize the receptor subtype involved.

Main Results:

• Local application of 5-HT increased extracellular DA in the PFC in a dose-dependent manner, with a greater effect than in the striatum.
• Selective 5-HT2A and 5-HT3 antagonists did not block the 5-HT-induced DA increase.
• A selective 5-HT1B/1D antagonist (GR 127935) completely blocked the effect of 5-HT, while selective 5-HT1B agonists (CP 93,129 and CP 94,253) increased extracellular DA.

Conclusions:

• There is a functional interaction between DA and 5-HT pathways in the PFC.
• The 5-HT1B receptor subtype appears to mediate the increase in extracellular DA induced by 5-HT in the PFC.
• These findings suggest a potential therapeutic target for cognitive disorders involving PFC dysfunction.